{
  "symbol": "BIOCON.NS",
  "period": "quarterly",
  "data": [
    {
      "ticker": "BIOCON.NS",
      "date": "2024-06-30",
      "quarter": "Q2 2024",
      "fiscal_year": 2024,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2024-09-30",
      "quarter": "Q3 2024",
      "fiscal_year": 2024,
      "revenue": 35450000000.0,
      "gross_profit": 23624000000.0,
      "operating_income": 2655000000.0,
      "ebitda": 7439000000.0,
      "net_income": -160000000.0,
      "diluted_eps": null,
      "total_assets": 571279000000.0,
      "total_liabilities": 304079000000.0,
      "total_equity": 267200000000.0,
      "total_debt": 167708000000.0,
      "cash_and_equivalents": 16877000000.0,
      "current_assets": 151535000000.0,
      "current_liabilities": 158051000000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": 0.6276497005988024,
      "current_ratio": 0.9587728011844278,
      "operating_margin": 7.489421720733428,
      "net_profit_margin": -0.45133991537376583,
      "roe": -0.059880239520958084,
      "roa": -0.028007330918868013,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 20.98448519040903
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2024-12-31",
      "quarter": "Q4 2024",
      "fiscal_year": 2024,
      "revenue": 37730000000.0,
      "gross_profit": 24137000000.0,
      "operating_income": 3264000000.0,
      "ebitda": 8047000000.0,
      "net_income": 251000000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 8.650940895838854,
      "net_profit_margin": 0.665253114232706,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 21.327855817651738
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 43581000000.0,
      "gross_profit": 28847000000.0,
      "operating_income": 7885000000.0,
      "ebitda": 11258000000.0,
      "net_income": 3445000000.0,
      "diluted_eps": null,
      "total_assets": 587973000000.0,
      "total_liabilities": 310848000000.0,
      "total_equity": 277125000000.0,
      "total_debt": 183620000000.0,
      "cash_and_equivalents": 32267000000.0,
      "current_assets": 162862000000.0,
      "current_liabilities": 143338000000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": 0.6625890843482183,
      "current_ratio": 1.1362095187598544,
      "operating_margin": 18.092746839218925,
      "net_profit_margin": 7.904820908193938,
      "roe": 1.2431213351375732,
      "roa": 0.5859112578298663,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 25.83235813772057
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2025-06-30",
      "quarter": "Q2 2025",
      "fiscal_year": 2025,
      "revenue": 39101000000.0,
      "gross_profit": 25050000000.0,
      "operating_income": 2939000000.0,
      "ebitda": 8286000000.0,
      "net_income": 314000000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 7.516431804813176,
      "net_profit_margin": 0.8030485153832383,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 21.191273880463417
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2025-09-30",
      "quarter": "Q3 2025",
      "fiscal_year": 2025,
      "revenue": 42625000000.0,
      "gross_profit": 27155000000.0,
      "operating_income": 3624000000.0,
      "ebitda": 9165000000.0,
      "net_income": 845000000.0,
      "diluted_eps": null,
      "total_assets": 627598000000.0,
      "total_liabilities": 297046000000.0,
      "total_equity": 330552000000.0,
      "total_debt": 165355000000.0,
      "cash_and_equivalents": 42747000000.0,
      "current_assets": 187811000000.0,
      "current_liabilities": 162542000000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": 0.5002389941673322,
      "current_ratio": 1.1554613576798611,
      "operating_margin": 8.502052785923754,
      "net_profit_margin": 1.9824046920821115,
      "roe": 0.2556330017667417,
      "roa": 0.1346403270883591,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 21.501466275659826
    }
  ]
}